These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 28155335)
61. Pulmonary extraction and accumulation of lipid formulations of amphotericin B. Matot I; Pizov R Crit Care Med; 2000 Jul; 28(7):2528-32. PubMed ID: 10921589 [TBL] [Abstract][Full Text] [Related]
63. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model. Khan MA; Owais M J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592 [TBL] [Abstract][Full Text] [Related]
64. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen. Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409 [TBL] [Abstract][Full Text] [Related]
65. Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities. Ramaswamy M; Peteherych KD; Kennedy AL; Wasan KM Antimicrob Agents Chemother; 2001 Apr; 45(4):1184-91. PubMed ID: 11257033 [TBL] [Abstract][Full Text] [Related]
66. Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment. Falci DR; dos Santos RP; Wirth F; Goldani LZ Mycoses; 2011 Mar; 54(2):91-8. PubMed ID: 19878457 [TBL] [Abstract][Full Text] [Related]
67. Synthesis and evaluation of styrene-maleic acid copolymer conjugated amphotericin B. Banshoya K; Kaneo Y; Tanaka T; Yamamoto S; Maeda H Int J Pharm; 2019 Dec; 572():118719. PubMed ID: 31654700 [TBL] [Abstract][Full Text] [Related]
68. Safety, Tolerability, and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Approach to Parenteral Amphotericin B Administration. Hnik P; Wasan EK; Wasan KM Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32690643 [TBL] [Abstract][Full Text] [Related]
69. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study. Chamilos G; Luna M; Lewis RE; Chemaly R; Raad II; Kontoyiannis DP Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197 [TBL] [Abstract][Full Text] [Related]
70. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ Antimicrob Agents Chemother; 2002 Mar; 46(3):828-33. PubMed ID: 11850268 [TBL] [Abstract][Full Text] [Related]
71. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations. Jansook P; Fülöp Z; Ritthidej GC Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399 [TBL] [Abstract][Full Text] [Related]
72. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy. Fu T; Yi J; Lv S; Zhang B J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177 [TBL] [Abstract][Full Text] [Related]
74. Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections. Kuti JL; Kotapati S; Williams P; Capitano B; Nightingale CH; Nicolau DP Pharmacoeconomics; 2004; 22(5):301-10. PubMed ID: 15061680 [TBL] [Abstract][Full Text] [Related]
75. Potential lipid-based strategies of amphotericin B designed for oral administration in clinical application. Zhong X; Yang J; Liu H; Yang Z; Luo P Drug Deliv; 2023 Dec; 30(1):2161671. PubMed ID: 36601799 [TBL] [Abstract][Full Text] [Related]
76. AmBisome: relationship between the pharmacokinetic characteristics acquired by liposomal formulation and safety/efficacy. Takemoto K; Kanazawa K J Liposome Res; 2017 Sep; 27(3):186-194. PubMed ID: 27328721 [TBL] [Abstract][Full Text] [Related]
77. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis. Roy G; Galigama RD; Thorat VS; Mallela LS; Roy S; Garg P; Venuganti VVK Int J Pharm; 2019 Dec; 572():118808. PubMed ID: 31678387 [TBL] [Abstract][Full Text] [Related]